Driehaus Capital Management’s Alpine Immune Sciences Inc ALPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-23,566
Closed -$934K 457
2024
Q1
$934K Hold
23,566
0.01% 321
2023
Q4
$449K Buy
23,566
+4,930
+26% +$68.5K 0.01% 343
2023
Q3
$213K Buy
+18,636
New +$229K ﹤0.01% 384
2015
Q4
Sell
-40,524
Closed -$2.1M 657
2015
Q3
$2.1M Sell
40,524
-31,109
-43% -$2.04M 0.08% 274
2015
Q2
$4.34M Buy
+71,633
New +$4.27M 0.15% 165

Driehaus Capital Management's ALPN Position: Q2 2024 in Review

Driehaus Capital Management sold out of Alpine Immune Sciences Inc (ALPN) in Q2 2024, closing a stake of 23,566 shares — an estimated $934K sold.

Driehaus Capital Management first reported a position in ALPN in Q2 2015 and held it in 5 quarters. The position peaked at $4.34M in Q2 2015. 0 funds tracked by Wall St. Rank hold ALPN as of Q2 2024.

  • Driehaus Capital Management reported no remaining Alpine Immune Sciences Inc position as of Q2 2024 after selling out during the quarter.
  • Driehaus Capital Management sold 23,566 Alpine Immune Sciences Inc shares in Q2 2024, an estimated $934K.
  • Driehaus Capital Management first reported a position in Alpine Immune Sciences Inc in Q2 2015 and held it in 5 quarters.
  • Driehaus Capital Management's Alpine Immune Sciences Inc position peaked at $4.34M in Q2 2015.
  • 0 funds tracked by Wall St. Rank held Alpine Immune Sciences Inc as of Q2 2024.

Based on Driehaus Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.